Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism

Journal of Cell Biology

Volumn 139, Issue 4, 1997, Pages 995-1003

  Vecchi, Manuela ^a,b   Carpenter, Graham ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METALLOPROTEINASE; NEU DIFFERENTIATION FACTOR; PROTEASOME; PROTEIN TYROSINE KINASE; RECEPTOR;

ANIMAL CELL; ARTICLE; ENZYME ACTIVITY; HYDROLYSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

3T3 CELLS; ANIMALS; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; HUMANS; HYDROLYSIS; METALLOENDOPEPTIDASES; MICE; MOLECULAR WEIGHT; MULTIENZYME COMPLEXES; PEPTIDE FRAGMENTS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; UBIQUITINS;

ANIMALIA;

EID: 0030661989     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.139.4.995     Document Type: Article

References (53)

1. Arteaga, C.L., M.D. Johnson, G. Todderud, R.J. Coffey, G. Carpenter, and D.L. Page. 1991. Elevated content of the tyrosine kinase substrate phospholipase C-γ1 in primary human breast carcinomas. Proc. Natl. Acad. Sci. USA. 88:10435-10439.
2. Basler, K., B. Christen, and E. Hafen. 1991. Ligand-independent activation of the sevenless receptor tyrosine kinase changes the fate of cells in the developing drosophila eye. Cell. 64:1069-1081.
3. Baulida, J., M.H. Kraus, M. Alimandi, P.P. Di Fiore, and G. Carpenter. 1996. All ErbB receptors other than the epidermal growth factor receptor are endocytosis impaired. J. Biol. Chem. 271:5251-5257.
4. Birkedal-Hansen, H., W.G.I. Moore, M.K. Bodden, L.J. Windsor, B. Birkedal-Hansen, A. DeCarlo, and J.A. Engler. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4:197-250.
5. Black, R.A., C.T. Rauch, C.J. Kozlosky, J.J. Peschon, J.L. Slack, M.R. Wolfson, B.J. Castner, K.L. Stocking, P. Reddy, et al. 1997. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature. 385:729-733.
6. Bogyo, M., J.S. McMaster, M. Gaczynska, D. Tortorella, A.L. Goldberg, and H. Ploegh. 1997. Covalent modification of the active site threonine of proteasomal β subunits and the Escherichia coli homologue HsIV by a new class of inhibitors. Proc. Natl. Acad. Sci. USA. 94:6629-6634.
7. Brizzi, M.F., J.M. Blechman, G. Cavalloni, D. Givol, Y. Yarden, and L. Pegoraro. 1994. Protein kinase C-dependent release of a functional whole extracellular domain of the mast cell growth factor (MGF) receptor by MGF-dependent human myeloid cells. Oncogene. 9:1583-1589.
8. Cabrera, N., E. Díaz-Rodríguez, E. Becker, D. Martín-Zanca, and A. Pandiella. 1996. TrkA receptor ectodomain cleavage generates a tyrosine-phosphorylated cell-associated fragment. J. Cell Biol. 132:427-436.
9. 125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts. J. Cell Biol. 71:159-171.
10. Carraway, K.L. III., M.X. Sliwkowski, R. Akita, J.V. Platko, P.M. Guy, A. Nuijens, A.J. Diamonti, R.L. Vandlen, L.C. Cantley, and R.A. Cerione. 1994. The erbB3 gene product is a receptor for heregulin. J. Biol. Chem. 269: 14303-14306.
11. Carter, T.H., and H.J. Kung. 1994. Tissue-specific transformation by oncogenic mutants of epidermal growth factor receptor. Crit. Rev. Oncog. 5:389-428.
12. Coussens, L.M., and Z. Werb. 1996. Matrix metalloproteinases and the development of cancer. Chem. Biol. (Lond.) 3:895-904.
13. Delcarpio, J.B., N.A. Lanson, Jr., L.J. Filed, and W.C. Claycomb. 1991. Morphological characterization of cardiomyocytes isolated from a transplantable cardiac tumor derived from transgenic mouse atria (AT-1 Cells). Circ. Res. 69:1591-1600.
14. Downing, J.R., M.F. Roussel, and C.J. Sherr. 1989. Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol. Cell. Biol. 9:2890-2896.
15. Earp, H.S., T.L. Dawson, X. Li, and H. Yu. 1995. Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research. Breast Cancer Res. Treat. 35:115-132.
16. Ellis, L., D.O. Morgan, E. Clauser, R.A. Roth, and W.J. Rutter. 1987. A membrane-anchored cytoplasmic domain of the human insulin receptor mediates a constitutively elevated insulin-independent uptake of 2-deoxyglycose. Mol. Endocrinol. 1:15-24.
17. Fenteany, G., R.F. Standaert, W.S. Lane, S. Choi, E.J. Corey, and S.L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science. 268:726-731.
18. Galcheva-Oargova, Z., S.J. Therous, and R.J. Davis. 1995. The epidermal growth factor receptor is covalcntly linked to ubiquitin. Oncogene. 11:2649-2655.
19. Gassmann, M., F. Casagranda, D. Orioli, H. Simon, C. Lai, R. Klein, and G. Lemke. 1995. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature (Lond.). 378:390-394.
20. Goren, H.J., M.F. White, and C.R. Kahn. 1987. Separate domains of the insulin receptor contain sites of autophosphorylation and tyrosine kinase activity. Biochemistry. 26:2374-2382.
21. Horstman, D.A., R. Ball, and G. Carpenter. 1995. Baculovirus expression and purification of the second messenger enzyme phospholipase C-γ1, a tyrosine kinase substrate. Protein Expr. Purif. 6:278-283.
22. Hsuan, J.J., J. Downward, S. Clark, and M.D. Waterfield. 1989. Proteolytic generation of constitutive tyrosine kinase activity of the human insulin receptor. Biochem. J. 259:519-527.
23. Jeffers, M., G.A. Taylor, K.M. Weidner, S. Omura, and G.F. Vande Woude. 1997. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 17:799-808.
24. Lanson, N.A., Jr., C.C. Glembotski, M.E. Steinhelper, L.J. Field, and W.C. Claycomb. 1992. Gene expression and atrial natriuretic factor processing and secretion in cultured AT-1 cardiac myocytes. Circulation. 85:1835-1841.
25. Lebwohl, D.E., I. Nunez, M. Chan, and O.M. Rosen. 1991. Expression of inducible membrane-anchored insulin receptor kinase enhances deoxyglucose uptake. J. Biol. Chem. 266:386-390.
26. Lee, H.-W., L. Smith, G.R. Pettit, A. Vinitsky, and J.B. Smith. 1996. Ubiquitination of protein kinase C-α and degradation by the proteasome. J. Biol. Chem. 271:20973-20976.
27. 2-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence. J. Virol. 66: 374-385.
28. Liu, D., W.J. Rutter, and L.-H. Wang. 1993. Modulating effects of the extracellular sequence of the human insulinlike growth factor I receptor on its transforming and tumorigenic potential. J. Virol. 67:9-18.
29. Masui, H., A. Wells, C.S. Lazar, M.G. Rosenfeld, and G. Gill. 1991. Enhanced tumorigenesis of NR6 cells which express nondownregulating epidermal growth factor receptors. Cancer Res. 51:6170-6175.
30. c-erbB-2 receptor protein-tyrosine kinase induced by geldanamycin. J. Biol. Chem. 271:22796-22801.
31. Miyazawa, K., K. Toyama, A. Gotoh, P.C. Hendrie, C. Mantel, and H.E. Broxmeyer. 1994. Ligand-dependent polyubiquitination of c-kit gene product:a possible mechanism of receptor down modulation in M07e cells. Blood. 83:137-145.
32. Moss, M.L., S.-L.C. Jin, M.E. Milla, W. Burkhart, H.L. Carter, W.-J. Chen, W.C. Clay, J.R. Didsbury, D. Hassler, C.R. Hoffman, et al. 1997. Cloning of a disintegrin metalloproteinase that processes precursor tumor-necrosis factor-α. Nature. 385:733-736.
33. Mori, S., C.-H. Heldin, and L. Claesson-Welsh. 1992. Ligand-induced polyubiquitination of the platelet-derived growth factor β-receptor. J. Biol. Chem. 267:6429-6434.
34. Mori, S., L. Claesson-Welsh, Y. Okuyama, and Y. Saito. 1995. Ligand-induced polyubiquitination of receptor tyrosine kinases. Biochem. Biophys. Res. Comm. 213:32-39.
35. O'Bryan, J.P., Y.-W. Fridell, R. Koski, B. Varnum, and E.T. Liu. 1995. The transforming receptor tyrosine kinase, Axl, is posttranslationally regulated by proteolytic cleavage. J. Biol. Chem. 270:551-557.
36. Pawson, T., and J. Schlessinger. 1993. SH2 and SH3 domains. Curr. Biol. 3:434-442.
37. Pinkas-Kramarski, R., L. Soussan, H. Waterman, G. Levkowitz, I. Alroy, L. Klapper, S. Lavi, R. Seger, B.J. Ratzkin, M. Sela, and Y. Yarden. 1996. Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions. EMBO (Eur. Mol. Biol. Organ.) J. 15:2452-2467.
38. erbB4. Nature 366:473-475.
39. Rock, K.L., C. Gramm, L. Rothstein, K. Clark, R. Stein, L. Dick, D. Hwang, and A.L. Goldberg. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell. 78:761-771.
40. Savage, C.R., and S. Cohen. 1972. Epidermal growth factor and a new derivative. Rapid isolation procedures and biological and chemical characterization. J. Biol. Chem. 247:7609-7611.
41. Shoelson, S.E., M.F. White, and C.R. Kahn. 1988. Tryptic activation of the insulin receptor. Proteolytic truncation of the α-subunit releases the β-subunit from inhibitory control. J. Biol. Chem. 263:4852-4860.
42. Sliwkowski, M.X., G. Schaefer, R.W. Akita, J.A. Lofgren, V.D. Fitzpatrick, A. Nuijens, B.M. Fendly, R.A. Cerione, R.L. Vandlen, and K.L. Carraway III. 1994. Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. J. Biol. Chem. 269:14661-14665.
43. Sorkin, A., and C.M. Waters. 1993. Endocytosis of growth factor receptors. BioEssays. 6:375-382.
44. Steinhelper, M.E., N.A. Lanson, Jr., K.P. Dresdner, J.B. Delcarpio, A.L. Wit, W.C. Claycomb, and L.J. Field. 1990. Proliferation in vivo and in culture of differentiated adult atrial cardiomyocytes from transgenic mice. Am. J. Physiol. 259:H1826-H1834.
45. Tzahar, E., G. Levkowitz, D. Karunagaran, L. Yi, E. Peles, S. Lavi, D. Chang, N. Liu, A. Yayon, D. Wen, and Y. Yarden. 1994. ErbB-3 and ErbB-4 function as the respective low and high affinity receptors of all Neu differentiation factor/heregulin isoforms. J. Biol. Chem. 269:25226-25233.
46. Vecchi, M., J. Baulida, and G. Carpenter. 1996. Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J. Biol. Chem. 271: 18989-18995.
47. Wang, L.-H., B. Lin, S.-M.J. Jong, D. Dixon, L. Ellis, R.A. Roth, and W.J. Rutter. 1987. Activation of transforming potential of the human insulin receptor gene. Proc. Natl. Acad. Sci. USA. 84:5725-5729.
48. Wells, A., J.B. Welsh, C.S. Lazar, H.S. Wiley, G.N. Gill, and M.G. Rosenfeld. 1990. Ligand-induced transformation by noninternalizing epidermal growth factor receptor. Science. 247:962-964.
49. Yang, T., and D.M. Roden. 1996. Regulation of sodium current development in cultured atrial tumor myocytes (AT-1 cells). Am. J. Physiol. 271:H541-H547.
50. + channel mRNA in cultured atrial cardiac myocytes (AT-1 cells). Circ. Res. 75:870-878.
51. Yarden, Y., J.A. Escobedo, W.-J. Kuang, T.L. Yang-Feng, T.O. Daniel, P.M. Tremble, E.Y. Chen, M.E. Ando, R.N. Harkins, U. Francke, et al. 1986. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors. Nature. 323:226-232.
52. Yee, N.S., H. Langen, and P. Besmer. 1993. Mechanism of kit ligand, phorbol ester, and calcium-induced down regulation of c-kit receptors in mast cells. J. Biol. Chem. 268:14189-14201.
53. Yee, N.S., C.-W.M. Hsiau, H. Serve, K. Vosseller, P. Besmer. 1994. Mechanism of down-regulation of c-kit receptor. J. Biol. Chem. 269:31991-31998.